NLRP3 and colitis: NLRP3 inflammasome seems to act as a negative modulator of tumorigenesis in colitis-associated cancer (59), which is confirmatory to the study emphasizing the role of NLRP3 inflammasome in the regulation of intestinal homeostasis and thus protection against colitis (60).